LLNL researchers have continued to develop their pioneering DIW 3D-printed glass optics technology that allows for the 3D printing of single- and multi-material optical glass compositions in complex shapes. This LLNL invention further proposes incorporating dopants (including, but not limited to TiO2 and Pd) into slurries and inks for 3D printing of glass components that can then be directly…

LLNL’s high throughput method involves proteome-wide screening for linear B-cell epitopes using native proteomes isolated from a pathogen of interest and convalescent sera from immunized animals.

LLNL researchers have developed a custom resin formulation which uses a dispersing solvent and only a multifunctional monomer as the binding agent. The dispersing solvent system typically used has multiple components meant to achieve excellent dispersal of silica in order to create a flowable resin (rather than a paste). The dispersing agent has low vapor pressure, which allows the 3D printed…

LLNL has developed a novel process of production, isolation, characterization, and functional re-constitution of membrane-associated proteins in a single step. In addition, LLNL has developed a colorimetric assay that indicates production, correct folding, and incorporation of bR into soluble nanolipoprotein particles (NLPs).

LLNL has developed an approach, for formation of NLP/…